Bevacizumab: increased risk of venous thromboembolism
- 11 Downloads
KeywordsPublic Health Systematic Review Relative Risk Randomise Control Trial Bevacizumab
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
- 1.Nalluri SR, Chu D, Keresztes R, Zhu X, Wu S.Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis. JAMA: the Journal of the American Medical Association 300: 2277-2285, No. 19, 19 Nov 2008Google Scholar
© Adis International limited or Adis Data Information BV 2008